A detailed history of Hm Payson & CO transactions in Boston Scientific Corp stock. As of the latest transaction made, Hm Payson & CO holds 6,783 shares of BSX stock, worth $689,424. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,783
Previous 6,753 0.44%
Holding current value
$689,424
Previous $520,000 9.23%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$72.96 - $84.0 $2,188 - $2,520
30 Added 0.44%
6,783 $568,000
Q1 2024

Jun 20, 2024

BUY
$57.6 - $68.62 $4,780 - $5,695
83 Added 1.24%
6,753 $462,000
Q4 2023

Feb 13, 2024

SELL
$48.64 - $57.81 $45,527 - $54,110
-936 Reduced 12.31%
6,670 $385,000
Q3 2023

Nov 06, 2023

BUY
$50.19 - $54.68 $112,224 - $122,264
2,236 Added 41.64%
7,606 $401,000
Q2 2023

Jul 17, 2023

SELL
$49.72 - $54.64 $7,458 - $8,196
-150 Reduced 2.72%
5,370 $290,000
Q1 2023

Apr 18, 2023

BUY
$45.09 - $50.03 $193,255 - $214,428
4,286 Added 347.33%
5,520 $276,000
Q4 2022

Feb 06, 2023

SELL
$39.56 - $47.22 $2,175 - $2,597
-55 Reduced 4.27%
1,234 $57,000
Q3 2022

Oct 25, 2022

BUY
$36.71 - $109.66 $3,230 - $9,650
88 Added 7.33%
1,289 $50,000
Q2 2022

Aug 15, 2022

SELL
$35.24 - $47.1 $1,127 - $1,507
-32 Reduced 2.6%
1,201 $44,000
Q1 2022

May 12, 2022

BUY
$40.9 - $45.1 $1,349 - $1,488
33 Added 2.75%
1,233 $55,000
Q4 2020

Mar 10, 2021

BUY
$33.15 - $41.97 $4,972 - $6,295
150 Added 14.29%
1,200 $43,000
Q2 2020

Aug 13, 2020

BUY
$30.19 - $39.11 $7,547 - $9,777
250 Added 31.25%
1,050 $37,000
Q1 2020

Jul 01, 2020

SELL
$25.83 - $45.71 $7,077 - $12,524
-274 Reduced 25.51%
800 $26,000
Q4 2019

Feb 18, 2020

SELL
$37.87 - $45.37 $8,520 - $10,208
-225 Reduced 17.32%
1,074 $49,000
Q2 2019

Aug 15, 2019

BUY
$34.91 - $42.98 $45,348 - $55,831
1,299 New
1,299 $56,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $146B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Hm Payson & CO Portfolio

Follow Hm Payson & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.